- Home
- VRME vs PMCB Comparison
VRME vs PMCB Comparison
Compare VRME & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRME
- PMCB
- Stock Information
- Founded
- VRME 1999
- PMCB 1996
- Country
- VRME United States
- PMCB United States
- Employees
- VRME N/A
- PMCB N/A
- Industry
- VRME EDP Services
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VRME Technology
- PMCB Health Care
- Exchange
- VRME Nasdaq
- PMCB Nasdaq
- Market Cap
- VRME 14.5M
- PMCB 15.8M
- IPO Year
- VRME N/A
- PMCB N/A
- Fundamental
- Price
- VRME $1.36
- PMCB $1.81
- Analyst Decision
- VRME Buy
- PMCB
- Analyst Count
- VRME 1
- PMCB 0
- Target Price
- VRME $1.50
- PMCB N/A
- AVG Volume (30 Days)
- VRME 15.1K
- PMCB 37.3K
- Earning Date
- VRME 11-06-2024
- PMCB 09-17-2024
- Dividend Yield
- VRME N/A
- PMCB N/A
- EPS Growth
- VRME N/A
- PMCB N/A
- EPS
- VRME N/A
- PMCB 0.54
- Revenue
- VRME $25,428,000.00
- PMCB N/A
- Revenue This Year
- VRME $1.14
- PMCB N/A
- Revenue Next Year
- VRME $10.56
- PMCB N/A
- P/E Ratio
- VRME N/A
- PMCB $3.29
- Revenue Growth
- VRME N/A
- PMCB N/A
- 52 Week Low
- VRME $0.85
- PMCB $1.39
- 52 Week High
- VRME $2.45
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- VRME 56.99
- PMCB 50.47
- Support Level
- VRME $1.28
- PMCB $1.72
- Resistance Level
- VRME $1.43
- PMCB $1.95
- Average True Range (ATR)
- VRME 0.10
- PMCB 0.23
- MACD
- VRME -0.00
- PMCB -0.01
- Stochastic Oscillator
- VRME 72.00
- PMCB 48.33
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.